Empirical Asset Management LLC lifted its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Get Rating) by 54.5% during the 1st quarter, according to its most recent disclosure with the SEC. The firm owned 21,007 shares of the biopharmaceutical company’s stock after buying an additional 7,412 shares during the period. Gilead Sciences accounts for […]